Long-term efficacy and safety of canagliflozin monotherapy in patients with type 2 diabetes inadequately controlled with diet and exercise: Findings from the 52-week CANTATA-M study
- Kaj Stenlöf
- , William T. Cefalu
- , Kyoung Ah Kim
- , Esteban Jodar
- , Maria Alba
- , Robert Edwards
- , Cindy Tong
- , William Canovatchel
- , Gary Meininger
Research output: Contribution to journal › Article › peer-review
158
Scopus
citations